Sylvie Mazoyer

11.4k total citations
50 papers, 2.5k citations indexed

About

Sylvie Mazoyer is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Sylvie Mazoyer has authored 50 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 30 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Sylvie Mazoyer's work include BRCA gene mutations in cancer (25 papers), Genomic variations and chromosomal abnormalities (16 papers) and CRISPR and Genetic Engineering (15 papers). Sylvie Mazoyer is often cited by papers focused on BRCA gene mutations in cancer (25 papers), Genomic variations and chromosomal abnormalities (16 papers) and CRISPR and Genetic Engineering (15 papers). Sylvie Mazoyer collaborates with scholars based in France, United States and United Kingdom. Sylvie Mazoyer's co-authors include Nadine Puget, Gilbert Lenoir, Olga M. Sinilnikova, Monique Buisson, Henry T. Lynch, Olga Anczuków, Dominique Stoppa‐Lyonnet, Rosette Lidereau, D. Gareth Evans and Bruce A.J. Ponder and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and PLoS ONE.

In The Last Decade

Sylvie Mazoyer

47 papers receiving 2.4k citations

Peers

Sylvie Mazoyer

GENET

PFM

Anne Thornton United States

Najim Ameziane Netherlands

Nadine Puget France

Josephine C. Dorsman Netherlands

Sarah Reid United Kingdom

Martin A. Rooimans Netherlands

Eitan Zlotorynski Netherlands

Jana Karásková Canada

Reinhard Kalb Germany

Stéphan Gasca France

Anne Thornton United States

Sylvie Mazoyer

1.1k ×0.7

1.3k ×0.8

GENET

647 ×1.1

507 ×1.5

PFM

714 ×2.6

Citations per year, relative to Sylvie Mazoyer Sylvie Mazoyer (= 1×) peers Anne Thornton

Countries citing papers authored by Sylvie Mazoyer

Since Specialization

Citations

This map shows the geographic impact of Sylvie Mazoyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Mazoyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Mazoyer more than expected).

Fields of papers citing papers by Sylvie Mazoyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Mazoyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Mazoyer. The network helps show where Sylvie Mazoyer may publish in the future.

Co-authorship network of co-authors of Sylvie Mazoyer

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Mazoyer. A scholar is included among the top collaborators of Sylvie Mazoyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Mazoyer. Sylvie Mazoyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boutaud, Lucile, Virginie Hamel, Sophie Thomas, et al.. (2024). A Taybi-Linder syndrome-related RTTN variant impedes neural rosette formation in human cortical organoids. PLoS Genetics. 20(12). e1011517–e1011517.

Quēlin, Chloé, Laurent Pasquier, Philippe Loget, et al.. (2023). PHGDH-related microcephalic dwarfism in two fetuses: Expanding the phenotypical spectrum of L-serine biosynthesis defect. European Journal of Medical Genetics. 66(11). 104852–104852.

Benoit‐Pilven, Clara, Audrey Putoux, Claire Benetollo, et al.. (2020). Clinical interpretation of variants identified in RNU4ATAC, a non-coding spliceosomal gene. PLoS ONE. 15(7). e0235655–e0235655. 10 indexed citations

Sapey‐Triomphe, Laurie‐Anne, Gaëtan Lesca, Nicolas Chatron, et al.. (2020). A de novo frameshift pathogenic variant in TBR1 identified in autism without intellectual disability. Human Genomics. 14(1). 32–32. 5 indexed citations

Benoit‐Pilven, Clara, Audrey Putoux, Amandine Campan-Fournier, et al.. (2019). New insights into minor splicing—a transcriptomic analysis of cells derived from TALS patients. RNA. 25(9). 1130–1149. 26 indexed citations

Blein, Sophie, Laure Barjhoux, Francesca Damiola, et al.. (2015). Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2. PLoS ONE. 10(9). e0136192–e0136192. 9 indexed citations

Anczuków, Olga, Monique Buisson, Mélanie Léoné, et al.. (2012). BRCA2 Deep Intronic Mutation Causing Activation of a Cryptic Exon: Opening toward a New Preventive Therapeutic Strategy. Clinical Cancer Research. 18(18). 4903–4909. 52 indexed citations

Cox, David G., Laure Barjhoux, Daniel R. Barnes, et al.. (2011). The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Mutation. 32(9). 1004–1007. 39 indexed citations

Fontanière, Sandra, Delphine Magnin, Olga Anczuków, et al.. (2008). Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues. BMC Genetics. 9(1). 83–83. 100 indexed citations

10.

Sinilnikova, Olga M., et al.. (2006). BRCA1 and BRCA2 Mutations in Breast and Ovarian Cancer Syndrome: Reflection on the Creighton University Historical Series of High Risk Families. Familial Cancer. 5(1). 15–20. 17 indexed citations

11.

Kremeyer, Bárbara, Maria Soller, Kristina Lagerstedt‐Robinson, et al.. (2005). The BRCA1 exon 13 duplication in the Swedish population. Familial Cancer. 4(2). 191–194. 14 indexed citations

12.

Mazoyer, Sylvie. (2005). Genomic rearrangements in theBRCA1 andBRCA2 genes. Human Mutation. 25(5). 415–422. 122 indexed citations

13.

Barrois, Michel, et al.. (2004). Real‐time PCR‐based gene dosage assay for detecting BRCA1 rearrangements in breast–ovarian cancer families. Clinical Genetics. 65(2). 131–136. 40 indexed citations

14.

Puget, Nadine, Sophie Gad, Olga M. Sinilnikova, et al.. (2002). Distinct BRCA1 Rearrangements Involving the BRCA1 Pseudogene Suggest the Existence of a Recombination Hot Spot. The American Journal of Human Genetics. 70(4). 858–865. 88 indexed citations

15.

Gad, Sophie, Alain Aurias, Nadine Puget, et al.. (2001). Color bar coding the BRCA1 gene on combed DNA: A useful strategy for detecting large gene rearrangements. Genes Chromosomes and Cancer. 31(1). 75–84. 50 indexed citations

16.

Nathanson, Katherine L., Danielle Antin‐Ozerkis, Helen A. Shih, et al.. (2000). Screening for Genomic Rearrangements in Families with Breast and Ovarian Cancer Identifies BRCA1 Mutations Previously Missed by Conformation-Sensitive Gel Electrophoresis or Sequencing. The American Journal of Human Genetics. 67(4). 841–850. 117 indexed citations

17.

Rohlfs, Elizabeth M., Nadine Puget, Mark L. Graham, et al.. (2000). AnAlu-mediated 7.1 kb deletion ofBRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes and Cancer. 28(3). 300–307. 60 indexed citations

18.

Smith, Simon A., Jeff Stevens, Sylvie Mazoyer, et al.. (1996). Isolation of a Gene (DLG3) Encoding a Second Member of the Discs-Large Family on Chromosome 17q12–q21. Genomics. 31(2). 145–150. 31 indexed citations

19.

Gayther, Simon A., William Warren, Sylvie Mazoyer, et al.. (1995). Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation. Nature Genetics. 11(4). 428–433. 376 indexed citations

20.

Mazoyer, Sylvie, et al.. (1992). Genetic heterogeneity of early-onset familial breast cancer. Human Genetics. 89(4). 381–3. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact